Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Dose, Randomized, Multicenter Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of SR604 Injection in Patients With Von Willebrand Disease

NCT07640893 is registered in ClinicalTrials.gov with Shanghai RAAS Blood Products Co., Ltd. as lead sponsor.

NCT NCT07640893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07640893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Dose, Randomized, Multicenter Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of SR604 Injection in Patients With Von Willebrand Disease
Lead sponsor
Shanghai RAAS Blood Products Co., Ltd.
Phase
Phase 2
Overall status
Recruiting
Start date
November 26, 2025
Completion date
December 31, 2027
Enrollment
24 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

von willebrand disease (vwd)